Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: Molecular basis of the dominant-negative effect

Molecular Endocrinology

Volumn 18, Issue 7, 2004, Pages 1787-1797

  Brothers, Shaun P ^a,b   Cornea, Anda ^a,b   Janovick, Jo Ann ^a,b   Conn, P Michael ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; FLUORESCENT DYE; G PROTEIN COUPLED RECEPTOR; GONADORELIN; GONADORELIN RECEPTOR; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HYPOGONADOTROPIC HYPOGONADISM; INTRACELLULAR SPACE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN LOCALIZATION; WILD TYPE;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOPLASMIC RETICULUM; GENES, DOMINANT; GREEN FLUORESCENT PROTEINS; HUMANS; HYPOGONADISM; INDOLES; INOSITOL PHOSPHATES; MUTATION; PYRIDINES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LHRH; TRANSFECTION;

ANIMALIA; RODENTIA;

EID: 3042800569     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0091     Document Type: Article

References (35)

1. Seminara SB, Hayes FJ, Crowley Jr WF 1998 Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallman's syndrome): pathophysiological and genetic considerations. Endocr Rev 19:521-539
2. De Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E 1997 A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 337:1597-1602
3. Leanos-Miranda A, Ulloa-Aguirre A, Ji TH, Janovick JA, Conn PM 2003 Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans. J Clin Endocrinol Metab 88:3360-3367
4. Lin X, Janovick JA, Brothers S, Blomenrohr M, Bogerd J, Conn PM 1998 Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation. Mol Endocrinol 12:161-171
5. Maya-Nunez G, Janovick JA, Conn PM 2000 Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression. Endocrine 13:401-407
6. Arora KK, Chung HO, Catt KJ 1999 Influence of a species-specific extracellular amino acid on expression and function of the human gonadotropin-releasing hormone receptor. Mol Endocrinol 13:890-896
7. Maya-Nunez G, Janovick JA, Ulloa-Aguirre A, Soderlund D, Conn PM, Mendez JP 2002 Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site. J Clin Endocrinol Metab 87:2144-2149
8. Conn PM, Leanos-Miranda A, Janovick JA 2002 Protein origami: therapeutic rescue of misfolded gene products. Mol Interv 2:308-316
9. Janovick JA, Maya-Nunez G, Conn PM 2002 Rescue of hypogonadotropic- causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. J Clin Endocrinol Metab 87:3255-3266
10. Couzin J 2002 Protein structure. Harmless proteins twist into troublemakers. Science 296:28-29
11. Dobson CM 2001 The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci 356:133-145
12. Sanders CR, Nagy JK 2000 Misfolding of membrane proteins in health and disease: the lady or the tiger? Curr Opin Struct Biol 10:438-442
13. Belloti V, Mangione P, Stoppini M 1999 Biological activity and pathological implications of misfolded proteins. Cell Mol Life Sci 55:977-991
14. Dobson CM 1999 Protein misfolding, evolution and disease. Trends Biochem Sci 24:329-332
15. Kopito RR, Ron D 2000 Conformational disease. Nat Cell Biol 2:E207-E209
16. Sherman MY, Goldberg AL 2001 Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15-32
17. Angers S, Salahpour A, Bouvier M 2002 Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42:409-435
18. Breitwieser GE 2004 G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. Circ Res 94:17-27
19. Conn PM, Rogers D, Stewart J, Niedel J, Sheffield T 1982 Conversion of a gonadotropin-releasing hormone antagonist to an agonist. Nature 296:653-655
20. Conn PM, Rogers D, McNeil R 1982 Potency enhancement of a GnRH agonist: GnRH-receptor microaggregation stimulates gonadotropin release. Endocrinology 111:335-337
21. Cook JV, Eidne KA 1997 An intramolecular disulfide bond between conserved extracellular cysteines in the GnRH receptor is essential for binding and activation. Endocrinology 138:2800-2806
22. Buhlmann N, Leuthauser K, Muff R, Fischer JA, Born W 1999 A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology 140:2883-2890
23. Morfis M, Christopoulos A, Sexton PM 2003 RAMPs: 5 years on, where to now? Trends Pharmacol Sci 24:596-601
24. Lin X, Cornea A, Janovick JA, Conn PM 1998 Visualization of unoccupied and occupied gonadotropin-releasing hormone receptors in living cells. Mol Cell Endocrinol 146:27-37
25. Janovick JA, Goulet M, Bush E, Greer J, Wettlaufer DG, Conn PM 2003 Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor. J Pharmacol Exp Ther 305:608-614
26. Janovick JA, Ulloa-Aguirre A, Conn PM 2003 Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression. Endocrine 22:317-328
27. Blomenrohr M, Bogerd J, Leurs R, Goos H 2002 Differences in structure-function relations between nonmammalian and mammalian GnRH receptors: what we have learnt from the African catfish GnRH receptor. Prog Brain Res 141:87-93
28. Cemerikic B, Zamah R, Ahmed MS 1994 Opioids regulation of human chorionic gonadotropin release from trophoblast tissue is mediated by gonadotropin releasing hormone. J Pharmacol Exp Ther 268:971-977
29. Dragatsis I, Papazafiri P, Zioudrou C, Gerozissis K 1995 Opioids modify the release of LH at the pituitary level: in vitro studies with entire rat pituitaries. J Endocrinol 145:263-270
30. Law PY, Wong YH, Loh HH 2000 Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389-430
31. McArdle CA, Davidson JS, Willars GB 1999 The tail of the gonadotrophin-releasing hormone receptor: desensitization at, and distal to, G protein-coupled receptors. Mol Cell Endocrinol 151:129-136
32. Kaykas A, Yang-Snyder J, Heroux M, Shah KV, Bouvier M, Moon RT 2004 Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization. Nat Cell Biol 6:52-58
33. Cornea A, Janovick JA, Maya-Nunez G, Conn PM 2001 GnRH receptor microaggregation. Rate monitored by fluorescence resonance energy transfer. J Biol Chem 276:2153-2158
34. Leanos-Miranda A, Janovick JA, Conn PM 2002 Receptor-misrouting: unexpectedly prevalent and rescuable etiology in GnRHR-mediated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4825-4828
35. Huckle WR, Conn PM 1987 Use of lithium ion in measurement of stimulated pituitary inositol phospholipid turnover. Methods Enzymol 141:149-155